辐射瘤学的现代进展:每个瘤学家应该知道的知识
Rimsha J Afzal1, Christina C Huang2, Kaitlyn Lapen3
1Kentucky College of Osteopathic Medicine, Pikeville, KY.
JCO oncology practice
|March 2, 2026
概括
放射性瘤学已在强度调节辐射疗法和MR Linac等精确技术方面取得重大进展,提高了癌症治疗的准确性并减少了副作用. 新的应用和与免疫治疗的结合正在扩大其作用,尽管获得和成本仍然是挑战.
科学领域:
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
- 癌症治疗方法 癌症治疗方法
背景情况:
- 放射性瘤学已经在50多年里从广泛的技术发展到高度合规的,精确引导的治疗方法.
- 技术创新使得精确的,针对患者的辐射输送成为可能,改善了治疗结果并减少了副作用.
研究的目的:
- 审查辐射瘤技术和应用中的关键进展.
- 讨论辐射疗法在转移性疾病和与免疫疗法结合治疗中不断扩大的作用.
- 确定阻碍广泛采用辐射创新的挑战.
主要方法:
- 文献综述综合技术创新 (IMRT,SBRT,MR Linac,粒子束,放射性药物,自适应规划).
- 对转移性疾病的扩大应用和与免疫疗法结合的分析.
- 讨论包括金融毒性,获取差异和行政负担在内的挑战.
主要成果:
- 技术进步导致了更准确的辐射传递,并减少了副作用负担.
- 放射治疗越来越多地用于转移性疾病的治疗,改善了在寡头转移性环境中无进展的生存率.
- 将辐射与免疫疗法结合起来显示出协同效应,重塑治疗范式.
结论:
- 放射性瘤学的创新为癌症治疗提供了更高的准确性和更低的毒性.
- 放射治疗的作用正在扩大,特别是与转移性疾病的免疫治疗相结合.
- 解决成本,访问和行政障碍等挑战对于这些进步的广泛采用至关重要.
相关概念视频
Radiation: Applications
1.9K
The average temperature of Earth is the subject of much current discussion. Earth is in radiative contact with both the Sun and dark space; it receives almost all its energy from the radiation of the Sun and reflects some of it into outer space. Dark space is very cold, about 3 K, so Earth radiates energy into it. For instance, heat transfer occurs from soil and grasses, the rate of which can be so rapid that frost can occur on clear summer evenings, even in warm latitudes.
The average...
The average...
1.9K
Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
X-ray Imaging
10.8K
German physicist Wilhelm Röntgen (1845–1923) was experimenting with electrical current when he discovered that a mysterious and invisible "ray" would pass through his flesh but leave an outline of his bones on a screen coated with a metal compound. In 1895, Röntgen made the first durable record of the internal parts of a living human: an "X-ray" image (as it came to be called) of his wife’s hand. Scientists worldwide quickly began their own experiments with...
10.8K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Positron Emission Tomography
7.8K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
7.8K


